Katalog Plus
Bibliothek der Frankfurt UAS
Bald neuer Katalog: sichern Sie sich schon vorab Ihre persönlichen Merklisten im Nutzerkonto: Anleitung.
Dieses Ergebnis aus BASE kann Gästen nicht angezeigt werden.  Login für vollen Zugriff.

P144 PHENOTYPIC CHARACTERISATION OF HEART FAILURE WITH PRESERVED EJECTION FRACTION ACCORDING TO BODY MASS INDEX: SUBANALYSIS OF THE ARGENTINE ARFEY-PRESER REGISTRY

Title: P144 PHENOTYPIC CHARACTERISATION OF HEART FAILURE WITH PRESERVED EJECTION FRACTION ACCORDING TO BODY MASS INDEX: SUBANALYSIS OF THE ARGENTINE ARFEY-PRESER REGISTRY
Authors: Renna, Nicolás Federico; Coronel, María Lorena; Echazarreta, Diego; Moris, Maria Cecilia; Ceballos, A; Cursack, Guillermo; Colque, Roberto; Brocal, L; Poy, Carlos; Perna, Eduardo
Source: Journal of Hypertension ; volume 42, issue Suppl 3, page e111 ; ISSN 0263-6352 1473-5598
Publisher Information: Ovid Technologies (Wolters Kluwer Health)
Publication Year: 2024
Description: Background: Nutritional status, characterised by body mass index (BMI), may influence therapeutic decisions in heart failure with preserved ejection fraction (HFpEF). The objectives of this study were to identify clinical and echocardiographic characteristics associated with nutritional status and to analyse therapeutic strategies in HFpEF patients in Argentina. Materials and Methods: This prospective, multicentre observational registry enrolled outpatients or those discharged from hospitals, with prior informed consent. The study spanned from December 2022 to February 2024. Inclusion criteria were: 1) presence of current signs and symptoms, LVEF ≥50%, 2) structural heart disease with LVH, LAE, or average E/e’ ≥15 on Doppler, 3) elevated natriuretic peptides: sinus rhythm: NTproBNP >125 pg/ml or BNP >35 pg/ml; Atrial fibrillation/flutter: NTproBNP >375 pg/ml or BNP >105 pg/ml; and 5) commitment to 6-month and 1-year follow-ups. Exclusion criteria comprised: 1) acute coronary syndrome, 2) coronary artery bypass grafting, or valve replacement within the preceding 3 months, 3) confirmed infiltrative or hypertrophic cardiomyopathy, severe valvular disease, 4) severe illness with
Document Type: article in journal/newspaper
Language: English
DOI: 10.1097/01.hjh.0001063448.16251.2e
Availability: https://doi.org/10.1097/01.hjh.0001063448.16251.2e; https://journals.lww.com/10.1097/01.hjh.0001063448.16251.2e
Accession Number: edsbas.626ECA12
Database: BASE